CYTK FY 2025 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M+376.6% YoY

Gross Profit

$78M88.5% margin

Operating Income

-$612M-695.4% margin

Net Income

-$785M-891.6% margin

EPS (Diluted)

$-6.54

Cash Flow

Operating Cash Flow

-$510M

Free Cash Flow

-$535M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$2.1B

Stockholders' Equity

-$660M

Cash & Equivalents

$882M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$18M	+376.6%
Gross Profit	$78M	-$321M	+124.3%
Operating Income	-$612M	-$536M	-14.2%
Net Income	-$785M	-$590M	-33.2%